Food for thought: Immunotoxicology: Challenges in the 21st century and in vitro opportunities

Altex

Volumn 30, Issue 4, 2013, Pages 411-426

  Hartung, Thomas ^a,b   Corsini, Emanuela ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Alternative methods; Immune system; Toxicity testing; Toxicology for the 21st century; Xenobiotics

Indexed keywords

ENVIRONMENTAL CHEMICAL; PYROGEN; SUPERANTIGEN; IMMUNOTOXIN;

ADVERSE OUTCOME; ARTICLE; AUTOIMMUNITY; CYTOKINE PRODUCTION; HAZARD; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; NONHUMAN; TOXICITY TESTING; ANIMAL; ANIMAL TESTING ALTERNATIVE; METHODOLOGY; POLLUTANT; REVIEW;

ANIMAL TESTING ALTERNATIVES; ANIMALS; ENVIRONMENTAL POLLUTANTS; HUMANS; IMMUNOTOXINS; TOXICITY TESTS;

EID: 84893129066     PISSN: 1868596X     EISSN: 18688551     Source Type: Journal    
DOI: 10.14573/altex.2013.4.411     Document Type: Article

References (89)

1. Adler, S., Basketter, D., Creton, S., et al. (2011). Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol 85, 367-485.
2. Basketter, D. A., Clewell, H., Kimber, I., et al. (2012). A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing - t4 report. ALTEX 29, 3-91.
3. Bloemena, E., Roos, M. T. L., Van Heijst, J. L. A. M., et al. (1989). Whole-blood lymphocyte cultures. J Immunol Methods 122, 161-167.
4. Blom, W. M. W., van Nielen, W. G. L. W., de Groene, E. M. E., and Albers, R. R. (2009). A cell-based screening assay for natural killer cell activity. Int Immunopharmacol 9, 746-752.
5. Bremer, S., Pellizzer, C., Hoffmann, S., Seidle, T., and Hartung, T. (2007). The development of new concepts for assessing reproductive toxicity applicable to large scale toxicological programmes. Curr Pharm Des 13, 3047-3058.
6. Burns-Naas, L. A., Hastings, K. L., Ladics, G. S., et al. (2008). What's so special about the developing immune system? Int J Toxicol 27, 223-524.
7. Carfì, M., Gennari, A., Malerba, I., et al. (2007). In vitro tests to evaluate immunotoxicity: A preliminary study. Toxicology 229, 11-22.
8. Casati, S., Aeby, P., Basketter, D. A., et al. (2005). Dendritic cells as a tool for the predictive identification of skin sensitisation hazard. Altern Lab Anim 33, 47-62.
9. Collinge, M., Burns-Naas, L. A., Chellman, G. J., et al. (2012). Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendations. J Immunotoxicol 9, 210-230.
10. Colosio, C., Birindelli, S., Corsini, E., et al. (2005). Low level exposure to chemicals and immune system. Toxicol Appl Pharmacol 207, 320-328.
11. Corsini, E., Birindelli, S., Fustinoni, S., et al. (2005). Immunomodulatory effects of EBDTCs on agricultural workers occupationally exposed to the fungicide mancozeb. Toxicol Appl Pharmacol 208, 178-185.
12. Corsini, E. (2006). Human immunotoxicology: Consequences and mechanisms. Toxicol Lett 164, S313.
13. Corsini, E., Codecà, I., Mangiaratti, S., et al. (2007). Immunomodulatory effects of the herbicide propanil on cytokine production in humans: In vivo and in vitro exposure. Toxicol Appl Pharmacol 222, 202-210
14. Corsini, E. and Roggen, E. L. (2009). Immunotoxicology: opportunities for non-animal test development. Altern Lab Anim 37, 387-397.
15. Corsini, E., Oukka, M., Pieters, R., et al. (2011). Alterations in regulatory T-cells: rediscovered pathways in immunotoxicology. J Immunotoxicol 8, 251-257.
16. Corsini, E., Sokooti, M., Galli, C. L., et al. (2013). Pesticide induced immunotoxicity in humans: a comprehensive review of the existing evidence. Toxicology 307, 123-135.
17. Coutant, K. D. K., de Fraissinette, A. B. A., Cordier, A. A., and Ulrich, P. P. (1999). Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicol Sci 52,189-198.
18. Czaja, M. J., Xu, J., Ju, Y., et al. (1994). Lipopolysaccharide- neutralizing antibody reduces hepatocyte injury from acute hepatotoxin administration. Hepatology 19, 1282-1289.
19. Daneshian, M., von Aulock, S., and Hartung, T. (2009). Assessment of pyrogenic contaminations with validated human whole-blood assay. Nature Protoc 4, 1709-1721.
20. Dean, J. H., Luster, M., Munson, A. E., and Kimber, I. (1994). Immunotoxicology and Immunopharmacology. CRC Press LLC.
21. Dean, J. H., House, R. V., and Luster, M. (2007). Immunotoxicology: Effects of and response to drugs and chemicals. In A. W. Hayes (ed.), Principles and Methods of Toxicology (1755-1796). 5th edition. Philadelphia, USA: Taylor & Francis.
22. Descotes, J. (2004). Health consequences of immunotoxic effects. In J. Descotes (ed.), Immunotoxicology of Drugs and Chemicals: An Experimental and Clinical Approach. Principles and Methods of Immunotoxicology (55-126). Amsterdam, The Netherlands: Elsevier.
23. Descotes, J. and Ravel, G. (2005). Role of natural killer cells in immunotoxicity: an update. Expert Rev Clin Immunol 1, 603-608.
24. Descotes, J. (2006). Methods of evaluating immunotoxicity. Expert Opin Drug Metab Toxicol 2, 249-259.
25. DeWitt, J. C., Peden-Adams, M. M., Keil, D. E., and Dietert, R. R. (2012). Current status of developmental immunotoxicity: early-life patterns and testing. Toxicologic Pathology 40, 230-236.
26. Díaz, H. G., Marrero, Y., Hernández, I., et al. (2003). 3D-MEDNEs: an alternative "in silico" technique for chemical research in toxicology. 1. prediction of chemically induced agranulocytosis. Chem Res Toxicol 16, 1318-1327.
27. Dietert, R. R. (2008). Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment. J Immunotoxicol 5, 401-412.
28. Dietert, R. R. (ed.) (2010). Immunotoxicity Testing. Totowa, NJ, USA: Humana Press.
29. DiPietro, L. A. (1995). Wound healing: the role of the macrophage and other immune cells. Shock 4, 233-240.
30. Dutton, R. W. R. and Mishell, R. I. R. (1967). Cell populations and cell proliferation in the in vitro response of normal mouse spleen to heterologous erythrocytes. Analysis by the hot pulse technique. J Exp Med 126, 443-454.
31. Environmental Defense Fund (1997). Toxic ignorance. 1-65. http://bit.ly/17URkLP
32. Elsässer-Beile, U., Kleist von, S., Lindenthal, A., et al. (1993). Cytokine production in whole blood cell cultures of patients undergoing therapy with biological response modifiers or 5-fluorouracil. Cancer Immunol Immunother 37, 169-174.
33. Feingold, B. J., Vegosen, L., Davis, M., et al. (2010). A niche for infectious disease in environmental health: Rethinking the toxicological paradigm. Environ Health Perspect 118, 1165-1172.
34. Ferrario, D. and Rabbit, R. R. (2012). Analysis of the proposed EU regulation concerning biocide products and its opportunities for alternative approaches and a toxicology for the 21st century (t4 report). ALTEX 29, 157-172.
35. Fletcher, M. A., Baron, G. C., Ashman, M. R., et al. (1987). Use of whole blood methods in assessment of immune pa provement of human dendritic cell culture for immunotoxicological investigations. Cell Biol Toxicol 22, 243-255.
36. Ilbäck, N. G. and Friman, G. (2007). Interactions among infections, nutrients and xenobiotics. Crit Rev Food Sci Nutr 47, 499-519.
37. Institóris, L., Siroki, O., Dési, I., et al. (1998). Extension of the protocol of OECD guideline 407 (28-day repeated dose oral toxicity test in the rat) to detect potential immunotoxicity of chemicals. Human Exp Toxicol 17, 206-211.
38. Jaworska, J., Harol, A., Kern, P. S., et al. (2011). Integrating non-animal test information into an adaptive testing strategy - skin sensitization proof of concept case. ALTEX 28, 211-225.
39. Jones, C. F. and Grainger, D. W. (2009). In vitro assessments of nanomaterial toxicity. Adv Drug Delivery Rev 61, 438-456.
40. Kadow, S., Jux, B., Chmill, S., and Esser, C. (2009). Small molecules as friends and foes of the immune system. Future Med Chem 1, 1583-1591.
41. Kaminski, N. E., Faubert Kaplan, B. E., and Holsapple, M. P. (2007). Toxic responses of the immune system. In C. D. Klaassen (ed.), Casarett and Doull's Toxicology (485-555). 7th edition. New York, USA: McGraw Hill Professional.
42. Kilburn, K. H. and Warshaw, R. H. (1994). Chemical-induced autoimmunity. In J. H. Dean, M. I. Luster, A. E. Munson, and I. Kimber (eds.), Immunotoxicology and Immunopharmacology (523-538). 2nd edition. New York, USA: Raven Press.
43. Kim, G. G. G., Donnenberg, V. S. V., Donnenberg, A. D. A., et al. (2007). A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: Comparisons to a 4 h 51Cr-release assay. J Immunol Methods 325, 6-16.
44. Kirkwood, T. B. L. (2008). A systematic look at an old problem. Nature 451, 644-647.
45. Knutsen, B. B. (1978). Chemically induced agranulocytosis. 2 cases of bone marrow disorder after exposure to paint, sealing-wax and glue. Tidsskr Nor Laegeforen 98, 888-890.
46. Koeper, L. M. and Vohr, H. W. (2009). Functional assays are mandatory for correct prediction of immunotoxic properties of compounds in vitro. Food Chem Toxicol 47, 110-118.
47. Kosuda, L. L. and Bigazzi, E. P. (1996). Chemical-induced autoimmunity. In R. R. Smialowicz and M. P. Holsapple (eds.), Experimental Immunotoxicology (419-468). Boca Raton, FL, USA: CRC Press.
48. Lam-Tse, W. K. W., Lernmark, A. A., and Drexhage, H. A. H. (2002). Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity? Springer Semin Immunopathol 24, 297-321.
49. Langezaal, I., Coecke, S., and Hartung, T. (2001). Whole blood cytokine response as a measure of immunotoxicity. Toxicol In Vitro 15, 313-318.
50. Langezaal, I., Hoffmann, S., Hartung, T., and Coecke, S. (2002). Evaluation and prevalidation of an immunotoxicity test based on human whole-blood cytokine release. Altern Lab Anim 30, 581-595.
51. Lankveld, D., Van Loveren, H., and Baken, K. (2010). In vitro testing for direct immunotoxicity: State of the art. Meth Mol Biol 598, 401-423.
52. Laskin, D. L. and Pendino, K. J. (1995). Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 35, 655-677.
53. Leist, M., Gantner, F., Naumann, H., et al. (1997). Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology 112, 923-934.
54. Leist, M., Gantner, F., Künstle, G., and Wendel, A. (1998). Cytokine-mediated hepatic apoptosis. Rev Physiol Biochem Pharmacol 133, 109-155.
55. Luebke, R. (2012). Immunotoxicant screening and prioritization in the twenty-first century. Toxicol Pathol 40, 294-299.
56. Luster, M. I., Portier, C., Pait, D. G., et al. (1992). Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fund Appl Toxicol 18, 200-210.
57. Luster, M. I. and Rosenthal, G. J. (1993). Chemical agents and the immune response. Environ Health Perspect 100, 219-226
58. Luster, M. I., Portier, C., Pait, D. G., et al. (1993). Risk assessment in immunotoxicology. II. Relationship between immune and host resistance tests. Fund Appl Toxicol 21, 71-82.
59. Luster, M. I., Simeonova, P. P., Gallucci, R. M., et al. (2001). Role of inflammation in chemical-induced hepatotoxicity. Toxicol Lett 120, 317-321.
60. Luster, M. I. and Gerberick, G. F. (2010). Immunotoxicology testing: past and future. Methods Mol Biol 598, 3-13.
61. Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. (2008). Cancer-related inflammation. Nature 454, 436-444.
62. Mishell, R. I. R. and Dutton, R. W. R. (1967). Immunization of dissociated spleen cell cultures from normal mice. J Exp Med 126, 423-442.
63. Morales, A. and Ottenhof, P. C. (1983). Clinical application of a whole blood assay for human natural killer (NK) cell activity. Cancer 52, 667-670.
64. Negro, G. D., Bonato, M., and Gribaldo, L. (2001). In vitro bone marrow granulocyte-macrophage progenitor cultures in the assessment of hematotoxic potential of the new drugs. Cell Biol Toxicol 17, 95-105.
65. Nolan, J. P. (2010). The role of intestinal endotoxin in liver injury: A long and evolving history. Hepatology 52, 1829-1835.
66. Pessina, A., Albella, B., Bueren, J., et al. (2001). Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. Toxicol In Vitro 15, 729-740.
67. Pfaller, T. T., Colognato, R. R., Nelissen, I. I., et al. (2010). The suitability of different cellular in vitro immunotoxicity and genotoxicity methods for the analysis of nanoparticle-induced events. Nanotoxicology 4, 52-72.
68. Philip, M., Rowley, D. A., and Schreiber, H. (2004). Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 4, 433-439.
69. Pieters, R. (2007). Detection of autoimmunity by pharmaceu ticals. Methods 41, 112-117.
70. Reuben, S. (2010). Reducing Environmental Cancer Risk: What We Can Do Now: 2008-2009 Annual Report, President's Cancer Panel. Bethesda.
71. Riminton, D. S., Hartung, H. P., and Reddel, S. W. (2011). Managing the risks of immunosuppression. Curr Opin Neurol 24, 217-223.
72. Roder, J. C. J., Haliotis, T. T., Klein, M. M., et al. (1980). A new immunodeficiency disorder in humans involving NK cells. Nature 284, 553-555.
73. Rooney, A. A., Luebke, R. W., Selgrade, M. J., and Germolec, D. R. (2012). Immunotoxicology and its application in risk assessment. Conserv Genet 101, 251-287.
74. Rovida, C. and Hartung, T. (2009). Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t4). ALTEX 26, 187-208.
75. Rovida, C., Longo, F., and Rabbit, R. R. (2011). How are reproductive toxicity and developmental toxicity addressed in REACH dossiers? ALTEX 28, 273-294.
76. Shao, J., Katika, M. R., Schmeits, P. C., Hendriksen, P. J., et al. (2013). Toxicogenomics-based identification of mechanisms for direct immunotoxicity. Toxicol Sci, Epub ahead of print.
77. Schindler, S., Asmus, S., von Aulock, S., et al. (2004). Cryopreservation of human whole blood for pyrogenicity testing. J Immunol Methods 294, 89-100.
78. Schindler, S., Spreitzer, I., Loschner, B., et al. (2006). International validation of pyrogen tests based on cryopreserved human primary blood cells. J Immunol Methods 316, 42-51.
79. Schindler, S., Aulock von, S., Daneshian, M., and Hartung, T. (2009). Development, validation and applications of the monocyte activation test for pyrogens based on human whole blood. ALTEX 26, 265-277.
80. Schneider, M. and Hartung, T. (2001). Induction of the chemokines IL-8 and MCP-1 in human whole blood by a cell-lysate of human fibroblast cells. Immunol Lett 75, 163-165.
81. Sodemann, U., Bistrup, C., and Marckmann, P. (2011). Cancer rates after kidney transplantation. Danish Medical Bulletin Sodemann 58, A4342.
82. Su, G. L. (2002). Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 283, G256-G265.
83. Sundwall, A., Andersson, B., Balls, M., et al. (1994). Workshop: Immunotoxicology and in vitro possibilities. Toxicol In Vitro 8, 1067-1074.
84. van der Star, B. J., Vogel, D. Y. S., Kipp, M., et al. (2012). In vitro and in vivo models of multiple sclerosis. CNS and Neurological Disorders - Drug Targets 11, 570-588.
85. von Aulock, S., Boneberg, E. M., Diterich, I., and Hartung, T. (2004). Granulocyte colony-stimulating factor (filgrastim) treatment primes for increased ex vivo inducible prostanoid release. J Pharmacol Exp Ther 308, 754-759.
86. Wakelin, S. J., Sabroe, I., Gregory, C. D., et al. (2006). "Dirty little secrets" - Endotoxin contamination of recombinant proteins. Immunol Lett 106, 1-7.
87. Weir, G. M., Liwski, R. S., and Mansour, M. (2011). Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines. Cancers 3, 3114-3142.
88. Wood, S. C., Karras, J. G., and Holsapple, M. P. (1992). Integration of the human lymphocyte into immunotoxicological investigations. Fundamental Appl Toxicol 18, 450-459.
89. Zitvogel, L., Apetoh, L., Ghiringhelli, F., and Kroemer, G. (2008). Immunological aspects of cancer chemotherapy. Nat Rev Immunol 8, 59-73.